Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.75 USD | -1.00% | -1.36% | +0.65% |
May. 08 | Syndax Pharmaceuticals Q1 Net Loss Widens | MT |
May. 08 | Transcript : Syndax Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.65% | 1.85B | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- SNDX Stock
- News Syndax Pharmaceuticals, Inc.
- Syndax Pharmaceuticals Plans $150 Million Public Offering of Common Stock